Back to today’s briefing

Story perspectives

FDA and NIH Shift Focus to Human-Relevant Research

5/20/2025

50 8

Summary

Story summary

Animal models have played a vital role in medical advancements, paving the way for treatments like insulin and cancer immunotherapy. Yet, with over 90% of drugs failing in human trials, their limitations are stark. Recent moves by the FDA and NIH to focus on human-relevant methods promise a groundbreaking shift in biomedical research, offering hope for more effective therapies.

1 of 1

Story summary

Animal models have played a vital role in medical advancements, paving the way for treatments like insulin and cancer immunotherapy. Yet, with over 90% of drugs failing in human trials, their limitations are stark. Recent moves by the FDA and NIH to focus on human-relevant methods promise a groundbreaking shift in biomedical research, offering hope for more effective therapies.